Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Clinical Cardiology|March 18, 2010
Primary percutaneous coronary interventions in nonagenariansMichael Koutouzis, Lars Grip, Göran Matejka, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2010
Radial vs. femoral approach for primary percutaneous coronary intervention in octogenariansMichael Koutouzis, Göran Matejka, Göran Olivecrona, et al.Heart & Lung : the Journal of Critical Care|February 7, 2003
Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trialInger Ekman, Björn Fagerberg, Björn Andersson, et al.International Journal of Cardiology|January 28, 2009
Recurrent bare metal stent thrombosis: six years, single center experienceMichael Koutouzis, Per Albertsson, Dan Ioanes, et al.Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|June 3, 2010
Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shockMichael Koutouzis, Oscar Kolsrud, Per Albertsson, et al.Therapeutics and Clinical Risk Management|February 12, 2009
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuriaElmir Omerovic, Gerhard Brohall, Markus Müller, et al.Heart (British Cardiac Society)|April 14, 2011
Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Michael Koutouzis, Bo Lagerqvist, Stefan James, et al.International Journal of Cardiology|July 16, 2008
Switch from abciximab to eptifibatide during percutaneous coronary interventionMagnus Wahlin, Per Albertsson, Thomas Karlsson, et al.Vascular Health and Risk Management|September 23, 2010
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarctionElmir Omerovic, Truls Råmunddal, Per Albertsson, et al.Cardiology|August 1, 2012
Stress-induced cardiomyopathy in Sweden: evidence for different ethnic predisposition and altered cardio-circulatory statusTomas Schultz, Yangzhen Shao, Björn Redfors, et al.Pageof 2